Bulls vs Bears updated 6/18/15
Bullish- Qtrly Sales up +110% Y/Y
- Qtrly Gross Profit up +110% Y/Y
- Clinical trialin progress in patients that have large chronic and difficult wounds with exposed bone and tendon
- Final FDA study design and endpoints on confirmatory clinical trial for diabetic foot ulcers.
- Revenues Q1 2015 were $21.0M,vs to $10.1M Q1 2014, an increase of 109%.
- Gross profit was $16.4M Q1 2015 vs $7.8M Q1 2014, an increase of 110%
- Profitable; EPS $0.04 Q1 2015
Bearish
- Qtrly Sales may be slowing, +9% Q/Q vs range of 12 - 32%, in previous qtrs
- Insider sell 3 mo -20K, Sell/Tot=1/1; 12 mo Sell/Tot=1/1
No comments:
Post a Comment